Immunostimulant composition comprising at least one Toll-like receptor 7 or Toll-like receptor 8 agonist and a Tolllike receptor 4 agonist

Details for Australian Patent Application No. 2004305276 (hide)

Owner Sanofi Pasteur

Inventors Haensler, Jean; Burdin, Nicolas

Agent Davies Collison Cave

Pub. Number AU-B-2004305276

PCT Pub. Number WO2005/060966

Priority 0314995 19.12.03 FR

Filing date 20 December 2004

Wipo publication date 7 July 2005

Acceptance publication date 1 July 2010

International Classifications

A61K 31/4745 (2006.01)

A61K 31/685 (2006.01)

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/060966 Priority application(s): WO2005/060966

1 July 2010 Application Accepted

  Published as AU-B-2004305276

28 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004305291-Branched polyethylene glycol for linking polymer residues to antibodies

2004305273-Liquid jet writing tool